It is reported that PTTG1 and other two genes are associated with endocrine therapy resistance in breast cancer53; and PTTG1 was associated with poor prognosis of breast cancer patients and could promote tumor progression by regulating CCNA2 and CCNB254. This evidence concerns the gene CCNA2 and breast carcinoma.